ArticleThoracic cancer2020

Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab.

Tomoya Fukui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.